RND3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.951680E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.826200E-01
Normal-vs-Stage2
8.084900E-03
Normal-vs-Stage3
5.872400E-01
Normal-vs-Stage4
4.658200E-01
Stage1-vs-Stage2
2.969400E-01
Stage1-vs-Stage3
4.924000E-01
Stage1-vs-Stage4
4.985800E-01
Stage2-vs-Stage3
7.755000E-01
Stage2-vs-Stage4
6.982800E-01
Stage3-vs-Stage4
8.986200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.784120E-02
Normal-vs-AfricanAmerican
9.830800E-01
Normal-vs-Asian
3.099400E-01
Caucasian-vs-AfricanAmerican
4.380800E-01
Caucasian-vs-Asian
8.518400E-01
AfricanAmerican-vs-Asian
4.700600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.295600E-02
Normal-vs-Female
1.667690E-02
Male-vs-Female
8.263800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.262800E-01
Normal-vs-Age(41-60Yrs)
3.418800E-04
Normal-vs-Age(61-80Yrs)
1.681770E-01
Normal-vs-Age(81-100Yrs)
8.153600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.400600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.122200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.292200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.617400E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.071770E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.323200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.583400E-01
Normal-vs-Daily Drinker
6.517400E-01
Normal-vs-Weekly Drinker
3.705600E-01
Normal-vs-Occasional Drinker
4.098400E-02
Normal-vs-Social Drinker
3.462400E-01
Non Drinker-vs-Daily Drinker
6.299000E-01
Non Drinker-vs-Weekly Drinker
5.770400E-01
Non Drinker-vs-Occasional Drinker
7.991900E-02
Non Drinker-vs-Social Drinker
5.979600E-01
Daily Drinker-vs-Weekly Drinker
8.551600E-01
Daily Drinker-vs-Occasional Drinker
1.353430E-01
Daily Drinker-vs-Social Drinker
8.966600E-01
Weekly Drinker-vs-Occasional Drinker
2.467400E-01
Weekly Drinker-vs-Social Drinker
9.595400E-01
Occasional Drinker-vs-Social Drinker
1.902250E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.306600E-01
Normal-vs-Grade 2
9.589400E-01
Normal-vs-Grade 3
9.179800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.226300E-04
Grade 1-vs-Grade 3
1.436020E-03
Grade 1-vs-Grade 4
7.306600E-01
Grade 2-vs-Grade 3
4.600000E-01
Grade 2-vs-Grade 4
9.589400E-01
Grade 3-vs-Grade 4
9.179800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.446390E-01
Normal-vs-NonDiabetic
2.002100E-02
Diabetic-vs-NonDiabetic
7.657200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.320000E-01
Normal-vs-NoPancreatitis
2.052200E-02
Pancreatitis-vs-NoPancreatitis
9.009800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.180200E-01
Normal-vs-N1
9.701600E-03
N0-vs-N1
3.400200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.533000E-01
Normal-vs-TP53-NonMutant
6.026000E-01
TP53-Mutant-vs-TP53-NonMutant
3.65549999999937E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
